Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

Recurrent major depressive disorder (rMDD) is a relapsing-remitting disease with high morbidity and a 5-year risk of recurrence of up to 80%. This was a prospective pilot study to examine the potential diagnostic and prognostic value of targeted plasma metabolomics in the care of patients with rMDD...

Descripción completa

Detalles Bibliográficos
Autores principales: Mocking, Roel J. T., Naviaux, Jane C., Li, Kefeng, Wang, Lin, Monk, Jonathan M., Bright, A. Taylor, Figueroa, Caroline A., Schene, Aart H., Ruhé, Henricus G., Assies, Johanna, Naviaux, Robert K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801396/
https://www.ncbi.nlm.nih.gov/pubmed/33431800
http://dx.doi.org/10.1038/s41398-020-01182-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801396/
https://www.ncbi.nlm.nih.gov/pubmed/33431800
http://dx.doi.org/10.1038/s41398-020-01182-w

Ejemplares similares